Drug intelligence / Profile preview

Panax notoginseng Tablets

Development stage
Unknown
Lead developer
Yunnan Baiyao
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Panax notoginseng Tablets (PSQ project) is an innovative Traditional Chinese Medicine (TCM) Category 1.1 candidate developed by Yunnan Baiyao Group. Formulated as an oral tablet, the drug is derived from the roots of *Panax notoginseng* and is indicated for cardiovascular symptoms such as chest tightness, heart pain, palpitations, and dizziness caused by blood stasis in the heart veins. It is also being evaluated for the prevention of cardiovascular events in middle-aged and elderly patients. The project has completed Phase 2 clinical trials involving 704 cases and has finalized its pharmaceutical research phase.

Other names
Panax notoginseng Tablets (PSQ project)
02

Targets

GPIIb/IIIa (Integrin alpha-IIb/beta-3)FECH (Ferrochelatase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)F10 (Factor Xa)PTPN1 (Protein tyrosine phosphatase 1B)TNFA (Tumor necrosis factor alpha (soluble))ER (Estrogen receptor)IL-6 (Interleukin 6)Bcl-xL (Bcl-2-like protein 1)

Beyond the preview

Go deeper on Panax notoginseng Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panax notoginseng Tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call